Sector: MedicalNabi Biopharmaceuticals (NASDAQ: NABI)
Headlines
- Nabi Biopharmaceuticals to Hold Conference Call
Nov 16, 2009 08:31 AM | GSK, NABI
- GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
Nov 16, 2009 06:01 AM | GSK, NABI
- Nabi Biopharmaceuticals Announces Third Quarter 2009 Financial Results
Nov 05, 2009 04:06 PM | NABI
- Nabi Biopharmaceuticals Completes Sale of PentaStaph(TM) to GlaxoSmithKline PLC
Nov 04, 2009 09:16 AM | GSK, NABI
- Nabi Biopharmaceuticals Announces Withdrawal of Biotest's Indemnification Claim
Nov 03, 2009 05:02 PM | NABI
- Nabi Biopharmaceuticals Initiates Pivotal Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence
Nov 03, 2009 09:17 AM | NABI
- Nabi Biopharmaceuticals Participates in NicVAX(R) Phase IIb Study
Oct 28, 2009 09:02 AM | NABI
- Nabi Biopharmaceuticals to Announce Third Quarter Financial Results on November 5, 2009
Oct 27, 2009 10:31 AM | NABI
- Nabi Biopharmaceuticals Receives Grant Supporting Further NicVAX Development
Sep 29, 2009 11:02 AM | NABI
- Nabi Biopharmaceuticals to Present At Rodman & Renshaw's Annual Global Investment Conference
Sep 01, 2009 04:02 PM | NABI
- StockPreacher.com Issues Trading Outlook for Nabi Biopharmaceuticals
Aug 13, 2009 08:43 AM | AMGN, BAX, GENZ, NABI, WYE
- Nabi Biopharmaceuticals Announces Sale of PentaStaph(tm) to GlaxoSmithKline PLC
Aug 06, 2009 04:08 PM | NABI
- Nabi Biopharmaceuticals to Announce 2009 Second Quarter Financial Results on August 6, 2009
Jul 28, 2009 10:01 AM | NABI
- Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
Jul 13, 2009 08:31 AM | ACCP, CYTX, ECTE, JLI, NABI
- Nabi Biopharmaceuticals Receives Scientific Advice On NicVAX(r) From the European Medicines Agency
Jun 03, 2009 08:01 AM | NABI
- Nabi Biopharmaceuticals to Present At Noble Financial's Fifth Annual Equity Conference
Jun 02, 2009 10:41 AM | NABI
- Nabi Biopharmaceuticals Announces Withdrawal of Biotest's Indemnification Claim
Jun 01, 2009 10:01 AM | NABI
- Nabi Biopharmaceuticals Announces First Quarter 2009 Financial Results
May 06, 2009 04:07 PM | NABI
- Nabi Biopharmaceuticals to Announce 2009 First Quarter Financial Results On May 6, 2009
Apr 28, 2009 10:30 AM | NABI
- Nabi Biopharmaceuticals Announces Date for 2009 Annual Meeting of Shareholders
Apr 01, 2009 01:00 PM | NABI
- Form 4 NABI BIOPHARMACEUTICALS For: Nov 17 Filed by: Aryeh Jason (10K)
Nov 18, 2009 08:42 PM
- Form 4 NABI BIOPHARMACEUTICALS For: Nov 17 Filed by: LYNCH TIMOTHY P (10K)
Nov 18, 2009 08:37 PM
- Form 4 NABI BIOPHARMACEUTICALS For: Nov 16 Filed by: Kalnik Matthew W. (10K)
Nov 18, 2009 07:53 PM
- Form 4 NABI BIOPHARMACEUTICALS For: Nov 16 Filed by: Aryeh Jason (10K)
Nov 18, 2009 07:11 PM
- Form 4 KNOTT DAVID M For: Jun 29 (10K)
Jul 01, 2009 11:19 PM
- Form 4 SUDOVAR STEPHEN For: May 22 (10K)
May 27, 2009 06:23 PM
- Form 4 LYNCH TIMOTHY P For: May 22 (10K)
May 27, 2009 06:23 PM
- Form 4 NABI BIOPHARMACEUTICALS For: May 22 Filed by: JENCKES LINDA (10K)
May 27, 2009 06:23 PM
- Form 4 NABI BIOPHARMACEUTICALS For: May 22 Filed by: HARVEY RICHARD A JR (10K)
May 27, 2009 06:23 PM
- Form 4 CASTALDI DAVID L For: May 22 (10K)
May 27, 2009 06:19 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
NABI
|
Compare to S&P
|
| YTD |
6.27 %
|
-12.22 %
|
| 4 Weeks |
0.85 %
|
0.31 %
|
| 12 Weeks |
12.66 %
|
5.72 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -27.27 %
|
|
EPS Growth in Last Year: -75.00 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
